Literature DB >> 27116479

Short- and Long-Term Reproducibility of Intrahepatic Lipid Quantification by 1H-MR Spectroscopy and CT in Obesity.

Laura E Dichtel1, Alireza Eajazi, Karen K Miller, Martin Torriani, Miriam A Bredella.   

Abstract

OBJECTIVE: This study aimed to assess short- and long-term reproducibility of intrahepatic lipid (IHL) quantification by proton magnetic resonance spectroscopy (H-MRS) and computed tomography (CT).
METHODS: Sixteen obese subjects underwent H-MRS using a single-voxel point-resolved single-voxel spectroscopy sequence at 3 T and noncontrast single-slice CT of the liver. Measurements were repeated after 6 weeks and 6 months. Clinical parameters (weight, activity, serum lipids) were collected. Short-term (baseline to 6 weeks) and long-term (baseline to 6 months) reproducibility of IHL was assessed by coefficient of variance (CV), SD, and intraclass correlation coefficient (ICC).
RESULTS: Short-term reproducibility and long-term reproducibility of H-MRS were as follows: CV, 5.9% to 18.8%; SD, 0.7 to 1.9; and ICC, 0.998 to 0.995 (95% confidence interval, 0.942-0.999). Short-term reproducibility and long-term reproducibility of CT were as follows: CV, 4.4% to 14.2%; SD, 2.4 to 8.7; and ICC, 0.766 to 0.982 (95% confidence interval, 0.271-0.994). There was no significant change in clinical parameters (P > 0.3).
CONCLUSIONS: Proton magnetic resonance spectroscopy and CT are reproducible methods for short- and long-term quantification of IHL content. Our results can guide sample size calculations for interventional and longitudinal studies.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27116479      PMCID: PMC5025332          DOI: 10.1097/RCT.0000000000000423

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  41 in total

1.  A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis.

Authors:  Vlad Ratziu; Muhammad Y Sheikh; Arun J Sanyal; Joseph K Lim; Hari Conjeevaram; Naga Chalasani; Manal Abdelmalek; Anezi Bakken; Christophe Renou; Melissa Palmer; Robert A Levine; B Raj Bhandari; Melanie Cornpropst; Wei Liang; Benjamin King; Elsa Mondou; Franck S Rousseau; John McHutchison; Mario Chojkier
Journal:  Hepatology       Date:  2011-12-14       Impact factor: 17.425

2.  Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.

Authors:  Miriam A Bredella; Eleanor Lin; Danielle J Brick; Anu V Gerweck; Lindsey M Harrington; Martin Torriani; Bijoy J Thomas; David A Schoenfeld; Anne Breggia; Clifford J Rosen; Linda C Hemphill; Zida Wu; Nader Rifai; Andrea L Utz; Karen K Miller
Journal:  Eur J Endocrinol       Date:  2012-01-24       Impact factor: 6.664

Review 3.  Nonalcoholic fatty liver disease.

Authors:  Leon A Adams; Keith D Lindor
Journal:  Ann Epidemiol       Date:  2007-08-28       Impact factor: 3.797

4.  Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content.

Authors:  Jochem R van Werven; Johannes M Hoogduin; Aart J Nederveen; Andre A van Vliet; Ewa Wajs; Petra Vandenberk; Erik S G Stroes; Jaap Stoker
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

5.  Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity.

Authors:  Miriam A Bredella; Anu V Gerweck; Eleanor Lin; Melissa G Landa; Martin Torriani; David A Schoenfeld; Linda C Hemphill; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2013-07-03       Impact factor: 5.958

6.  Breath-hold 1H-magnetic resonance spectroscopy for intrahepatic lipid quantification at 3 Tesla.

Authors:  Miriam A Bredella; Reza Hosseini Ghomi; Bijoy J Thomas; Hugue A Ouellette; Dushyant V Sahani; Karen K Miller; Martin Torriani
Journal:  J Comput Assist Tomogr       Date:  2010 May-Jun       Impact factor: 1.826

Review 7.  Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.

Authors:  Nina F Schwenzer; Fabian Springer; Christina Schraml; Norbert Stefan; Jürgen Machann; Fritz Schick
Journal:  J Hepatol       Date:  2009-06-11       Impact factor: 25.083

Review 8.  Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis.

Authors:  Rajasekhara R Mummadi; Krishna S Kasturi; Swapna Chennareddygari; Gagan K Sood
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-19       Impact factor: 11.382

9.  Magnetic resonance imaging and spectroscopy for monitoring liver steatosis.

Authors:  Gary J Cowin; Julie R Jonsson; Judith D Bauer; Susan Ash; Azmat Ali; Emma J Osland; David M Purdie; Andrew D Clouston; Elizabeth E Powell; Graham J Galloway
Journal:  J Magn Reson Imaging       Date:  2008-10       Impact factor: 4.813

10.  Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index.

Authors:  Sang Won Lee; Seong Ho Park; Kyoung Won Kim; Eugene K Choi; Yong Moon Shin; Pyo Nyun Kim; Kyoung Ho Lee; Eun Sil Yu; Shin Hwang; Sung-Gyu Lee
Journal:  Radiology       Date:  2007-08       Impact factor: 11.105

View more
  1 in total

1.  Body Composition and Ectopic Lipid Changes With Biochemical Control of Acromegaly.

Authors:  Miriam A Bredella; Melanie Schorr; Laura E Dichtel; Anu V Gerweck; Brian J Young; Whitney W Woodmansee; Brooke Swearingen; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.